These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2068476)

  • 81. A comparative trial of aztreonam versus gentamicin in the treatment of urinary tract infections.
    Waller DA; Kendall SW; Whelan P
    Int Urol Nephrol; 1992; 24(3):221-7. PubMed ID: 1399377
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
    Ariza J; Xiol X; Esteve M; Fernández Bañeres F; Liñares J; Alonso T; Gudiol F
    Hepatology; 1991 Jul; 14(1):91-8. PubMed ID: 2066075
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aztreonam treatment of gram-negative septicemia.
    Pierard D; Boelaert J; Van Landuyt HW; Naessens A; Huyghens L; Lauwers S
    Antimicrob Agents Chemother; 1986 Feb; 29(2):359-61. PubMed ID: 3717938
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Temocillin treatment of serious infections due to gram-negative bacilli in an intensive care unit.
    Offenstadt G; Lesage D; Hericord P; Pinta P; Leaute JB; Amstutz P
    Drugs; 1985; 29 Suppl 5():213-20. PubMed ID: 3896741
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Safety profile of aztreonam in clinical trials.
    Newman TJ; Dreslinski GR; Tadros SS
    Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of aztreonam in treatment of complicated urinary tract infections in children.
    Kline MW
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S113-6; discussion S128-32. PubMed ID: 2682509
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Aztreonam.
    Cunha BA
    Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections.
    Friman G; Cars O; Bäck E; Beckman H; Carlsson M; Forssell J; Fredlund H; Neringer R; Odenholt-Tornqvist I; Rydén C
    Infection; 1989; 17(5):284-9. PubMed ID: 2689345
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Aztreonam as monotherapy in urinary tract infections with a systemic repercussion in patients with a relative contraindication for the use of aminoglycosides].
    Pedrajas JM; Pieltain R; Mesa N; Ramón P; García C; Pontes JC; Fernández-Cruz A
    Rev Clin Esp; 1993 Apr; 192(6):256-9. PubMed ID: 8497718
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical efficacy of carumonam.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1988; 14(10):665-7. PubMed ID: 3246211
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy of aztreonam in the treatment of neonatal sepsis.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hatziioannidis K; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S591-3. PubMed ID: 2068464
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical experience with aztreonam for treatment of infections in children.
    Stutman HR
    Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Aztreonam.
    Johnson DH; Cunha BA
    Med Clin North Am; 1995 Jul; 79(4):733-43. PubMed ID: 7791420
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Selective decontamination of the digestive tract with oral aztreonam and temocillin.
    van der Waaij D
    Rev Infect Dis; 1985; 7 Suppl 4():S628-34. PubMed ID: 3909318
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Infections due to gram-negative bacteria: an overview.
    Neu HC
    Rev Infect Dis; 1985; 7 Suppl 4():S778-82. PubMed ID: 3909337
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical pharmacology of aztreonam in healthy recipients and patients: a review.
    Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S605-12. PubMed ID: 3909317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.